Skip to content
healthcare.dev

Octreotide Acetate

NDC 67457-239, octreotide acetate, injection, solution, from Mylan Institutional LLC.

Product NDC
67457-239
Status
Listed
Labeler
Mylan Institutional LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA079198
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67457-239 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OCTREOTIDE ACETATE50 ug/mL

Pharmacologic classes

Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]

Package NDCNDC-11Package
67457-239-016745702390110 SYRINGE in 1 CARTON (67457-239-01) / 1 mL in 1 SYRINGE (67457-239-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2d78d5d1-77b2-4da1-98d4-d9c36e743ce2
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=67457-239

Use it

Look up 67457-239 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67457-239 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67457-239. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.